Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04626 (
erbB-2
)
5,251
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
RLIP76
is a modular protein that was identified as a putative effector of Ral, a GTPase activated during Ras signaling. To explore further the contribution of the Ral-
RLIP76
pathway to Ras signaling, we have looked for partners of
RLIP76
. Mu2, the medium chain of the AP2 complex is shown to interact with
RLIP76
. We show also that in vivo endogenous AP2 and
RLIP76
form a complex and that this in vivo interaction is independent of cells being stimulated by a growth factor. Furthermore,
RLIP76
differentiates AP2 from AP1 in vivo as
RLIP76
differentiates mu2 from mu1 in vitro and in two hybrid assays. We show that activated Ral interferes with both tranferrin receptor endocytosis and
epidermal growth factor (EGF) receptor
endocytosis in HeLa cells. We propose a model where the Ral-
RLIP76
pathway connects signal transduction and endocytosis through interaction on one hand between the Ras-Ral pathway and RLIP, on the other hand between RLIP and proteins belonging to the endocytotic machinery.
...
PMID:RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis. 1091 Jul 68